-
A New Era for AML Treatment: Integrating Novel Therapies and Global Collaboration
Professor Norbert Claude Gorin, the first Chair of the Global Committee of the European Society for Blood and Marrow Transplantation (EBMT), discussed the evolution of transplantation strategies for Acute Myeloid Leukemia (AML) and the importance of international cooperation. In an interview with Hematology Frontier during the second 2025 CTI conference in Hangzhou, he highlighted how decades of progress have…
-
Florent Malard on Tailoring GVHD Prophylaxis in the PTCy EraProfessor Florent Malard
At the 50th Annual Meeting of the EBMT in Glasgow, Scotland, Florent Malard, MD, PhD, a Professor of Hematology at Sorbonne University and Saint-Antoine Hospital, Paris, France, provided critical insights…
-
Bringing Together Global Expertise to Advance Uro-Oncology
During the 2025 ESMO Congress, the first and only ESMO-authorized “ESMO China Focus” Uro-Oncology Session was successfully held on October 19 in Berlin. The forum highlighted major advances in urothelial carcinoma and prostate cancer, bringing together Chinese and international experts for in-depth academic discussions and intellectual exchange. Experts agreed that data from landmark studies such…
-
When the breeze rises over West Lake and wisdom sends ripples across the world, when the Qiantang tide surges and innovation breaks waves toward a new era— the 2025 International Cell and Immunotherapy Congress officially opens
On November 14, 2025, the Second International Cell and Immunotherapy Congress convened in Hangzhou. The meeting is co-chaired by He Huang from the First Affiliated Hospital of Zhejiang University School of Medicine and Mohamad Mohty, President of the International Academy for Clinical Hematology (IACH). Clinical experts, basic researchers, young scientists, and representatives from biopharmaceutical enterprises…
-
Dr. Jianhong Zhong: Hepatectomy After Conversion Therapy Improves Survival in Initially Unresectable Hepatocellular Carcinoma
Patient Characteristics and Methodology Patients who underwent hepatectomy tended to be younger, have better liver function, and were more likely to exhibit a complete radiological response to conversion therapy. Baseline…
-
CCHIO 2025 | Professor Hu Xiaomei: Core Concepts, Clinical Practice, and Future Directions in Integrative Medicine for Leukemia
Editor’s Note: From November 6 to 9, 2025, the China Conference on Holistic and Integrative Oncology (CCHIO 2025) was successfully held in Kunming. As one of the largest and most…
-
CCHIO 2025 | Professor Zhu Jun: Breaking Barriers and Shaping Momentum — A New Blueprint for CAR-T in China Driven by Policy, Payment, and Innovation
From November 6 to 9, 2025, the China Conference on Holistic and Integrative Oncology (CCHIO 2025) was successfully held in Kunming. As one of the largest and most influential oncology…
-
CCHIO Chair Speaks | Professor Zhang Huilai: Integrative and Precision Oncology in Lymphoma — Practice, Progress, and Future Directions
From November 6 to 9, 2025, the China Conference on Holistic and Integrative Oncology (CCHIO 2025) was successfully held in the spring city of Kunming. As one of the largest…
Connecting Medical Expertise through Media